These findings suggest a more liberal approach to ascending aortic surgery in patients with BAV undergoing valve replacement, but improved risk stratification is needed. There is a significant growth ...

A 58-year-old man has undergone replacement of the ascending aorta in another hospital. A few months after surgery, the patient experienced pain in the lower limbs, shortness of breath, and ...

Considering all pathogeneses, ascending TAAs typically grow at 0.25 to 1 mm/y ... included symptomatic patients or patients scheduled to undergo aortic repair, or reported growth only after aortic ...

We recently published a list of Jim Cramer Put These 16 Stocks Under a Microscope. In this article, we are going to take a look at where Edwards Lifesciences (NYSE:EW) stands against other stocks that ...

In five patients, prior valve sparing ascending aortic replacement was indicated in the questionnaire. Data on left ventricular function were reported in 119 cases of which 3 (2.5%) had a decreased ...

Issuing a draft list of revised risk-based classification of cardiovascular and neurological devices, the Central Drugs ...

(2021) reconstructed ascending aortic geometries from ECG-gated CTA data ... simulations to predict hemodynamics in patients treated by thoracic endovascular aortic repair. Based on the acquired image ...

Transcatheter Aortic Valve Replacement Market outlook through 2035, highlighting key trends, growth drivers, challenges, and future opportunities ...

For patients with symptomatic aortic regurgitation at high surgical risk, a transcatheter aortic valve replacement system exceeded safety and performance goals, according to results of the ALIGN-AR ...

The “passive” notification led to more patients with severe AS undergoing valve replacement, but more can be done still.

Dapagliflozin reduced the risk of death or worsening heart failure in older patients with aortic stenosis who underwent transcatheter aortic-valve implantation.